Showing results (121-130 of 1,142) with videos related to

Sort By:
Pageof 115
Inflammation & Allergy Drug Targets|December 14, 2011
Modification of chemokine pathways and immune cell infiltration as a novel therapeutic approach in liver inflammation and fibrosisHenning W Zimmermann, Frank Tacke
Annals of Translational Medicine|October 21, 2016
Treatment for hepatitis B in patients with drug resistanceFrank Tacke, Daniela C Kroy
Immunobiology|August 22, 2006
Migratory fate and differentiation of blood monocyte subsetsFrank Tacke, Gwendalyn J Randolph
International Journal of Molecular Sciences|March 20, 2020
Recent Advances in Practical Methods for Liver Cell Biology: A Short OverviewSandra Torres, Zeinab Abdullah, Maximilian J Brol, et al.
Seminars in Cancer Biology|August 15, 2019
Danger matrix molecules orchestrate CD14/CD44 signaling in cancer developmentHeiko Roedig, Roxana Damiescu, Jinyang Zeng-Brouwers, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|January 17, 2004
Agmatine (decarboxylated arginine), a modulator of liver cell homeostasis and proliferationBettina Kribben, Jörg Heller, Jonel Trebicka, et al.
United European Gastroenterology Journal|June 19, 2019
Establishing an indwelling peritoneal catheter as a standard procedure for hospitalized patients with ascites: Retrospective data on feasibility, effectiveness and safetyKatharina Stratmann, Daniel Fitting, Stefan Zeuzem, et al.
Zeitschrift Fur Gastroenterologie|June 7, 2019
[Proton pump inhibitors in patients with liver cirrhosis - a survey among hepatologists in Germany]Thomas Horvatits, Andreas Drolz, Malte Wehmeyer, et al.
Deutsches Arzteblatt International|January 8, 2025
Acute on Chronic Liver FailureJonel Trebicka, Michael Praktiknjo, Kai-Henrik Peiffer, et al.
Trials|February 28, 2018
Antifibrotic and molecular aspects of rifaximin in alcoholic liver disease: study protocol for a randomized controlled trialBjørn Stæhr Madsen, Jonel Trebicka, Maja Thiele, et al.
Pageof 115